Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
European Cytokine Network
|
April 17, 2002
Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk
Nadine C Fernandez, Caroline Flament, Florent Crépineau, et al.
Bulletin Du Cancer
|
November 12, 2003
[NK cell-based immunotherapy: new prospects and involvement of dendritic cells]
Christophe Borg, Julien Taieb, Magali Terme, et al.
Blood Cells, Molecules & Diseases
|
July 20, 2005
The potential of exosomes in immunotherapy of cancer
Nathalie Chaput, Julien Taïeb, Noël Schartz, et al.
Bulletin Du Cancer
|
November 12, 2003
[Exosomes and anti-tumour immunotherapy]
Nathalie Chaput, Fabrice Andre, Noël E C Schartz, et al.
BMC Cancer
|
March 5, 2014
Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab
Diane Goéré, Nathalie Gras-Chaput, Anne Aupérin, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
September 25, 2007
Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference
Nathalie Chaput, Stéphane De Botton, Michel Obeid, et al.
Cytokine & Growth Factor Reviews
|
December 25, 2007
Dendritic cells and innate defense against tumor cells
Evelyn Ullrich, Cédric Ménard, Caroline Flament, et al.
Cancer Research
|
June 6, 2013
Potent immunomodulatory effects of the trifunctional antibody catumaxomab
Diane Goéré, Caroline Flament, Sylvie Rusakiewicz, et al.
Cancer Research
|
December 15, 2010
Cyclophosphamide induces differentiation of Th17 cells in cancer patients
Sophie Viaud, Caroline Flament, Mustapha Zoubir, et al.
Plos One
|
March 26, 2009
Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha
Sophie Viaud, Magali Terme, Caroline Flament, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
European Cytokine Network
|
April 17, 2002
Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk
Nadine C Fernandez, Caroline Flament, Florent Crépineau, et al.
Bulletin Du Cancer
|
November 12, 2003
[NK cell-based immunotherapy: new prospects and involvement of dendritic cells]
Christophe Borg, Julien Taieb, Magali Terme, et al.
Blood Cells, Molecules & Diseases
|
July 20, 2005
The potential of exosomes in immunotherapy of cancer
Nathalie Chaput, Julien Taïeb, Noël Schartz, et al.
Bulletin Du Cancer
|
November 12, 2003
[Exosomes and anti-tumour immunotherapy]
Nathalie Chaput, Fabrice Andre, Noël E C Schartz, et al.
BMC Cancer
|
March 5, 2014
Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab
Diane Goéré, Nathalie Gras-Chaput, Anne Aupérin, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
September 25, 2007
Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference
Nathalie Chaput, Stéphane De Botton, Michel Obeid, et al.
Cytokine & Growth Factor Reviews
|
December 25, 2007
Dendritic cells and innate defense against tumor cells
Evelyn Ullrich, Cédric Ménard, Caroline Flament, et al.
Cancer Research
|
June 6, 2013
Potent immunomodulatory effects of the trifunctional antibody catumaxomab
Diane Goéré, Caroline Flament, Sylvie Rusakiewicz, et al.
Cancer Research
|
December 15, 2010
Cyclophosphamide induces differentiation of Th17 cells in cancer patients
Sophie Viaud, Caroline Flament, Mustapha Zoubir, et al.
Plos One
|
March 26, 2009
Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha
Sophie Viaud, Magali Terme, Caroline Flament, et al.
Page
of 4